Health and Fitness Health and Fitness
Mon, September 19, 2011
Sun, September 18, 2011
Sat, September 17, 2011
Fri, September 16, 2011

Jazz Pharmaceuticals Announces Presentation at the UBS Global Life Sciences Conference in New York on September 20


Published on 2011-09-16 03:00:45 - Market Wire
  Print publication without navigation


Jazz Pharmaceuticals Announces Presentation at the UBS Global Life Sciences Conference... -- PALO ALTO, Calif., Sept. 16, 2011 /PRNewswire/ --

Jazz Pharmaceuticals Announces Presentation at the UBS Global Life Sciences Conference in New York on September 20

[ ]

PALO ALTO, Calif., Sept. 16, 2011 /PRNewswire/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: [ JAZZ ]) announced today that the company will make a presentation at the UBS Global Life Sciences Conference in New York on Tuesday, September 20, 2011 at 9:30 a.m. Eastern Time. Company management will provide a business and financial update.  

A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at [ www.jazzpharmaceuticals.com ]. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archived version of webcast will be available for at least one week on the Investors section of the company's website at [ www.jazzpharmaceuticals.com ].

About Jazz Pharmaceuticals

Jazz Pharmaceuticals, Inc. (Nasdaq: [ JAZZ ]) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information, see [ www.jazzpharmaceuticals.com ].

SOURCE Jazz Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.jazzpharmaceuticals.com ]

Contributing Sources